For medtech, device and pharma commercial leaders
Sales consulting for medical device and healthcare companies
revenue - amplified
Every result on page one sells a credential to a person. We work for the company that employs them. revenueify trains your reps, manages the cadence your managers run, and recruits the ones you are missing, all on one methodology and against one number.
One partner, three jobs
Train the team you employ
Customer Focused Selling® for the OR, the formulary meeting and the value analysis committee, not a course that helps someone get hired.
Manage the cadence
Outsourced and fractional sales management, so the training survives contact with a Monday morning.
Recruit what is missing
PXT Select® and behavioral interviewing, with a risk-free hiring guarantee.
Measure one number
A.I.M. establishes the baseline, and every engagement is judged against it.
The 2026 reality
What actually changed in how healthcare buys
Three shifts, each of them measured and published. Every number on this page carries the organisation, the report and the year, because in this category most of the numbers being quoted cannot be traced to anybody.
Share of healthcare professionals accessible to biopharma field teams, in a single year
Veeva Systems, Veeva Pulse Field Trends Report, 4Q24 data, published February 2025. Built on more than 600 million HCP interactions from over 80% of commercial biopharma field teams worldwide.
Of hospital purchasing decision-makers say decisions now take longer than in prior years
NAMSA, research conducted by SUAZIO, Hospital Purchasing Behavior and Procurement Trends of 2025, June 2025. Double-blinded interviews with 100 decision-makers averaging 8.3 years experience.
Of medical device companies get 70% or more of annual revenue through contracts, after the win
AcuityMD, 2024 Contracts Survey Report, more than 150 medtech professionals at director level or above, September 2024.
Read together, those three describe one thing: the selling motion that worked in 2019 does not reach the room any more, and the room got bigger and later.
The gap nobody is closing
Three things changed. Three things in our method answer them
This is the argument. Not a list of frameworks, but which specific framework closes which specific gap, and why the rest of the category is not built to.
Gap one
Access collapsed, so one meeting has to do twelve meetings' work
Half of the healthcare professionals who will still see a rep restrict themselves to three companies or fewer. Nearly 30% in internal medicine, oncology, psychiatry and urology restrict access to one. In oncology only 32% of providers are fully accessible and reps average 2.6 calls a day.
What closes it: the F.I.N.D. Interview System®. Facts, Important business objectives, Needs, Dreams, in that order, so a single conversation surfaces the clinical picture and the economic one at the same time. Paired with Everything DiSC®, so a rep reads the clinician in front of them inside the first thirty seconds rather than running the same script at four different people.
Access figures: Veeva Pulse Field Trends Report, February 2025. Oncology figures: ZS, Oncology sales planning, March 2024.
Gap two
The decision got wider, and clinical strength alone now loses it
Hospital buyers say the reason decisions slow down is that more departments join them. Their words: "More departments (clinical, financial, IT) become involved in decisions which slows down the workflow." Across B2B generally, buying groups run five to sixteen people over as many as four functions, and 74% show unhealthy internal conflict.
What closes it: OBJECTIVELens®. One view that puts the objectives, the roadblocks and the solution fit in front of clinical, financial and IT at once, with hard cost, soft cost and opportunity cost separated so the CFO and the surgeon are looking at the same picture. Getting to all of them in the first place is Three-Wide-Three-High.
NAMSA / SUAZIO, Hospital Purchasing Behavior and Procurement Trends of 2025, June 2025. Buying-group size and conflict figures: Gartner Sales Survey, 632 B2B buyers, published May 2025 -- cross-industry B2B, not healthcare-specific.
Gap three
The purchase order is the middle of the deal, and everyone trains the first half
If 68% of device companies take 70% or more of their revenue through contracts, then the revenue is not the signature. It is adoption, utilisation and expansion in the months after it. Every respondent in that study said they leave money on the table because of it.
What closes it: the right-hand side of the Bowtie Funnel. Most sales training stops at the close, because a funnel stops at the close. The bowtie does not. It is the half of the model that governs whether a won contract turns into used product, and it is the half nobody else in this category teaches.
AcuityMD, 2024 Contracts Survey Report, September 2024. Companies with advanced commercial capabilities achieved a CAGR 1.4 times higher than those with average capabilities: McKinsey & Company, Commercial capabilities: A predictor of growth for medtech companies, June 2024.
How we help
What we are actually asked to fix
Four jobs. Most companies start with one and add the others once the number moves.
The seat
Reps who can only sell clinically
They are credible in the room and invisible in the committee. We add the business conversation without taking away the clinical one.
The cadence
Managers who inspect instead of coach
A pipeline review is not coaching. We install the cadence and the language so the training is still there in month six.
The onboarding
Ramp that never ends
New hires who are technically trained and commercially untrained. There is no reliable public benchmark for medtech ramp time, which is part of the problem.
The expansion
Won deals that never became revenue
Contracts signed, product not adopted. This is the half of the model most training does not cover.
Your partner
Tyler Ebnet
Tyler founded revenueify to do one thing that the training industry does not do: stay on the number. Most vendors deliver a programme and leave. revenueify trains the team, installs the management cadence, and recruits into the gaps, under a single methodology, so there is nobody to hand the problem to.
Customer Focused Selling® has been in the field since 1988. revenueify has carried it since 2022, and adapts it per industry from the buyer's actual buying process rather than from a generic script.
Why we are different
Everyone on page one sells a credential to a person
Search any healthcare sales training term and look at who ranks. Almost all of it is sold to an individual trying to get hired. The rest is sold to a learning and development department as a module. Neither of them is accountable for your number.
What page one is
The career schools
A ten-week programme sold to a candidate so they can get a job in the industry. Tuition is public and runs from a few hundred dollars to nearly twenty thousand. Useful, and aimed at a different buyer entirely.
What page two is
The module vendors
Corporate training catalogues and platform subscriptions sold into learning and development. Real capability, delivered and then handed back. Almost none of them publish a price.
What we are
revenueify
One partner who trains the reps, runs the management cadence, and recruits the people you are missing, on one methodology, measured against one number. If it is not moving, it is still ours.
The method
One method, installed in every seat
The same system, taught to the rep, run by the manager and hired against by the recruiter. That is what makes it survive past the workshop.
A.I.M. Assessment
The baseline. Where the revenue is actually leaking, in your data, before anybody proposes a programme. It is also the number every later result is measured against.
Customer Focused Selling®
The methodology underneath everything, in the field since 1988. Selling the outcome the customer is trying to reach rather than the specification of the thing you make.
F.I.N.D. Interview System®
The discovery discipline for a world where you get one meeting. Facts, Important business objectives, Needs, Dreams.
Everything DiSC®
Reading the clinician, the administrator and the economic buyer as different people who need different conversations, not one script delivered louder.
OBJECTIVELens®
One view that clinical, financial and IT can all agree on, with hard cost, soft cost and opportunity cost separated.
The Bowtie Funnel
The half after the signature. Adoption, utilisation and expansion, which is where most device revenue actually arrives.
The whole journey
Most sales training stops where this diagram turns around
The left side is the part every competitor teaches. The right side is where most medical device revenue actually arrives, and it is the reason a won contract and a used product are two different things.
Customer Focused Selling®
Foundational Sales Skills
Where to start
Programs for medtech, device and pharma teams
Pick the one that matches the problem you have this quarter. Every one of them starts from the same baseline assessment.
Training
Healthcare sales training
The mini-pillar. How the whole system is customised for medtech, device and pharma selling.
Training
Medical device sales training
For the device team you already employ. Programs, not a certificate someone earns to get hired.
Process
The medical device sales process
The seven stages, from clinical discovery to committee approval to adoption after the win.
Training
Pharmaceutical sales training
HCP engagement built for restricted access, with compliance in the method rather than bolted on.
Training
Orthopedic device sales training
The operating room, surgeon behavioral styles and the agency model.
Onboarding
Healthcare sales onboarding
New hire ramp that carries the method, the manager and the measurement together.
Certification
Certification for medical sales teams
Certify your own team on one method so "trained" means the same thing across the org.
Management
Outsourced sales management
When the gap is the manager, not the reps. A healthcare-specific version is coming; this is the main program.
Recruiting
Sales recruiting
PXT Select®, behavioral interviewing and a risk-free guarantee. A healthcare-specific version is coming; this is the main program.
Start here
A.I.M. Assessment
Start here if you are not sure which of the above you need. It tells you.
One partner
The training is not the product. The number is
There is a published figure for exactly this problem: 65% of healthcare professional engagements lack sales and marketing synchronisation, and 44% of key opinion leaders perceive a lack of coordination between the clinical, medical and sales teams talking to them.
That is not a training gap. It is a system gap, and you cannot buy it as a module. When the reps, the managers, the hiring profile and the measurement all run on one methodology, the customer stops meeting four different companies wearing the same badge.
- ✓One methodology from the assessment through to expansion
- ✓The people who trained your team are the people who manage the cadence
- ✓The hiring profile is built from the same behavioral model as the training
- ✓One baseline number, and we are still on it in month twelve
Veeva Systems, Veeva Pulse Field Trends Report, 4Q24 data, published February 2025.
Start with the baseline
Find out where the revenue is actually leaking
The A.I.M. Assessment reads your commercial motion the way we would read it in the first two weeks of an engagement, and tells you which of the programs above you actually need. It is a short read, and there is no pitch attached to it.
Get your A.I.M. Assessment
A short read on where your revenue is leaking. No pitch required.
Stop buying training and start buying the number
One partner for medtech and pharma revenue
Every other name in this category sells a credential to a person or a module to a department. We train the team you employ, run the cadence your managers need, recruit what you are missing, and stay on the number while it moves. Start with the assessment and find out which part is actually broken.